ARCHIVES

ACS Says New Tax Policy Hurts Charity Funds

This article is from The Cancer Letter archive.

Vol. 06 No. 17 | April 25, 1980

Download PDF Visit The Full Archive

Related Articles

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

November 28, 2003

Program Announcements

July 25, 1986

Decision Network Votes 14-11 for Laetrile Testing

September 29, 1978

NKTR-102 Shows 29 Percent Response in Phase II Study

September 30, 2011

In Brief: Mathews Could Help In Fighting OMB Obstruction Of Cancer Program; Easily Wins Senate Approval

August 1, 1975

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014